13F filer · CIK 1799883
5AM Venture Management, LLC
SAN FRANCISCO, CA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$287.9M
$-72.3M vs prior
Positions
16
New / sold out
0 / 4
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $93.2M
Top-10 weight
85.6%
Biggest buys vs Q1 2026
No new or increased positions this quarter.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ERASCA INC | -3,485,971 | -100.0% | $-56.4M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -580,945 | -100.0% | $-23.1M |
| Sold out | GH RESEARCH PLC | -572,665 | -100.0% | $-8.1M |
| Reduced | SURROZEN INC | -116,250 | -30.0% | $-3.0M |
| Sold out | RALLYBIO CORP | -291,788 | -100.0% | $-2.6M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | MAPLIGHT THERAPEUTICS INCCOM | 950,011 | $34.0M | 11.83% |
| 2 | TYRA BIOSCIENCES INCCOM | 1,029,298 | $32.9M | 11.42% |
| 3 | ENTRADA THERAPEUTICS INCCOM | 4,056,379 | $29.9M | 10.37% |
| 4 | PHARVARIS N VCOM | 797,600 | $27.6M | 9.58% |
| 5 | CAMP4 THERAPEUTICS CORPCOM | 5,869,091 | $25.6M | 8.91% |
| 6 | ARTIVA BIOTHERAPEUTICS INCCOM | 2,353,304 | $22.8M | 7.93% |
| 7 | TECTONIC THERAPEUTIC INCCOM | 606,660 | $20.9M | 7.24% |
| 8 | ZENTALIS PHARMACEUTICALS INCCOM | 3,947,913 | $19.1M | 6.65% |
| 9 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 497,270 | $18.5M | 6.43% |
| 10 | EYEPOINT INCCOM NEW | 1,050,000 | $15.0M | 5.22% |
6 more rows. Subscribe for $29/month to see every row, download the data and use the API.